Organigram Global (OGI) Fundamental Analysis: Revenue, Earnings & Valuation

7.33 / 10

Outperform

Fundamental analysis rates OGI as Outperform with a 7.3/10 quality score. Strengths include high inventory turnover and low current‑liabilities‑to‑total‑liabilities ratio. Weak points are a negative PB‑ROE and elevated cost‑of‑sales ratio. Overall fundamentals are deemed adequate and optimistic.

Analysis Checks(8/10)

Revenue-MV

Value0.57

Score3/3

Weight34.41%

1M Return8.11%

Total operating revenue (YoY growth rate %)

Value66.80

Score2/3

Weight0.47%

1M Return0.13%

Inventory turnover ratio

Value2.02

Score3/3

Weight-3.38%

1M Return-0.93%

Current liabilities / Total liabilities (%)

Value59.21

Score2/3

Weight1.33%

1M Return0.36%

PB-ROE

Value-0.67

Score1/3

Weight27.81%

1M Return7.56%

Long-term debt to working capital ratio (%)

Value0.55

Score3/3

Weight3.01%

1M Return0.87%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight-3.99%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value66.80

Score2/3

Weight0.19%

1M Return0.05%

Cost of sales ratio (%)

Value65.96

Score1/3

Weight-20.28%

1M Return-7.95%

Asset-MV

Value-0.55

Score3/3

Weight60.42%

1M Return11.61%

Is OGI undervalued or overvalued?

OGI scores 7.33/10 on fundamentals and holds a Discounted valuation at present. Backed by its 5.56% ROE, 6.15% net margin, 14.35 P/E ratio, 0.68 P/B ratio, and 131.44% earnings growth, these metrics solidify its Outperform investment rating.